Accelerator Corp., a Seattle company that provides management, space and financing to biotech start-ups, is coming to New York. Sometime this year, the company will set up its second location, probably at the Alexandria Center for Life Sciences, CEO Carl Weissman announced at Thursday's NYC Tech Connect's Emerging Technologies Summit. New York won the bid over seven other finalists, including San Diego, Houston, and London. "New York has a great critical mass of academic institutions," Mr. Weissman said. "It is underserved in terms of capital and management for biotech startups," which is what Accelerator provides.
To read the original article: Biotech startup program heads for NYC | Crain's New York Business
